Protyon molecular modeling

We can test drug efficacy quickly and efficiently through in silico methods, providing you with information before administering it to the patient. 

This brings a detailed understanding of drug-protein interactions at the molecular level that leads to improved treatment outcomes.

In silico molecular assays designed for the clinic

Computer simulations are being increasingly utilized in the health care to improve treatment outcomes and make clinical decisions more efficient. Accuracy and efficiency are key in health care, and these elements have been incorporated into the Protyon molecular analysis since its inception. By utilizing the latest advancements in structural biology and molecular modeling, our in silico assays achieve unparalleled accuracy.

Molecular analysis using digital twins of patients molecules

Protyon’s in silico assays create digital twins of proteins and molecules from patients. Our modeling pipelines analyze the effects of protein mutations utilizing their molecular structures.

Using our custom algorithms, Protyon’s analysis reports on the effectiveness of drugs for treatment  and the impact of mutations on protein activation.

Protein mutations change their structure and function

The function of proteins is determined by their amino acid sequence and structure. Structural information is at the heart of Protyon models and algorithms for both creating the digital twin of the patients’ molecules and their analysis for drug efficacy and protein activation. Protein mutations may be only small changes in their amino acid sequence, but can lead to large effects in protein structure and function. 

By working with molecular structures, Protyon’s in silico assays can achieve unprecedented accuracy in their predictions.

Unparalleled predictive power brings Protyon ahead of its competitors

Most companies offering molecular analyses for clinical use rely on in vitro molecular assays, which can be both time-consuming and costly. Protyon in comparison stands out by utilizing modern digital technologies. By making our analyses digital we are able to provide faster results and improved cost-efficiency compared to our competitors. Our custom algorithms incorporate structural information, ensuring high accuracy in our predictions.

Why use Protyon in silico analysis

Discover how molecular modeling predicts the effectiveness of targeted therapy

Protyon is trusted and utilized by hospitals and our partners

Talk to us

Feel free to reach out to us and book an appointment with one of our experts in the field of molecular modeling. We are here to support you. 

Please enable JavaScript in your browser to complete this form.
Hoang Nguyen
Chief Operation Officer